Clicky

AFT Pharmaceuticals Ltd  (AFP)

Description: AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.


Keywords: Pharmaceutical Clinical Trial Intellectual Property Ducting Pharmaceutical Distributor

Home Page: www.aftpharm.com

AFP Technical Analysis

AmericaFirst Quantitative Funds
,

Phone: 877-217-8363


Officers

Name Title
Dr. Hartley Atkinson Ph.D. Co-Founder, CEO, MD & Exec. Director
Ms. Marree Atkinson Co-Founder, Chief of Staff & Exec. Director
Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ CFO & Company Sec.
Mr. Murray Keith Group Marketing Mang.
Ms. Ioana Stanescu Head of Drug Devel.
Mr. Calvin Mackenzie Gen. Mang. of AFT Australia
Mr. Scott Crawford Gen. Mang. of Promoted Products Australasia & South East Asia
Ms. Louise Clayton Director of International Bus.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 17.0648
Trailing PE: 22.3
Price-to-Book MRQ: 6.6525
Price-to-Sales TTM: 2.5368
IPO Date:
Fiscal Year End: March
Full Time Employees: 97
Back to stocks